Nir Naor

CIK 1982278 · EVP, CFO & Treasurer · last filed 2026-07-23

Nir Naor is an EVP, CFO & Treasurer who has filed 6 SEC Form 4 insider transactions across 3 companies since 2023. The most recent filing, for STIM, was dated Jul 23, 2026. Current disclosed insider exposure totals $11.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$11.67M

Companies

3

Total Filings

6

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
STIM	EVP, CFO & Treasurer	500,000	$1.87	$935.0K	$0	1	2026-07-23
AXGN	CFO	260,868	$41.15	$10.73M	$0	2	2025-01-06
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted	Director	31,465	$0.75	$23.6K	$0	2	2025-01-03

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-07-23	STIM	Grant (A)	+500,000	$0	EDGAR
2026-05-20	—	Grant (A)	—	$0
2025-01-06	AXGN	Tax (F)	−39,132	-$595.6K	EDGAR
2025-01-03	BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted	Grant (A)	+30,666	$0	EDGAR
2024-01-04	AXGN	Grant (A)	+300,000	$0	EDGAR
2023-06-21	BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Delisted	Grant (A)	+11,999	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.